#Denmark #Water Technology #financing #Aquaporin #Kongens Lyngby

Aquaporin A/S: Update on Strategic Review and Financial Stability Initiatives

On November 7, 2025, Aquaporin A/S, a pioneering water technology company, announced an update regarding its ongoing strategic review aimed at boosting its financial position. The company, known for its advancement in water filtration biotechnology, is actively exploring various avenues for raising capital as it prepares for growth in the upcoming years.

Strategic Review Details

The strategic review was first initiated in August 2025, with Aquaporin’s Board of Directors emphasizing the need for additional capital due to the company's current financial situation. This review is essential for securing a sound financial footing as the company strives to achieve profitability in the near to mid-term.

Aquaporin is targeting gross proceeds of between DKK 125 million to DKK 175 million through equity options, strategic transactions, or partnerships that may emerge from ongoing discussions with both existing shareholders and potential investors. The company has made it clear that these dialogues are still in the preliminary stages and no firm decisions have yet been made.

Planned Approaches

To accommodate a variety of potential outcomes from the strategic review, the Board has proposed an array of measures that will be discussed in an extraordinary general meeting scheduled for December 1, 2025. The proposals aim to provide Aquaporin with the necessary flexibility to adapt to evolving market conditions and conversations with key stakeholders.

The company aims to finalize the capital-raising arrangements before the end of the year, ideally achieving this before the first half of 2026, with timelines contingent on necessary authorizations, market dynamics, and investor outlook.

Importance of Financial Stability

The pressing need for additional capital is underscored by Aquaporin's ambition to bolster operations and scale up efforts in innovative water filtration solutions. The company's unique technology, known as Aquaporin Inside®, is derived from Nobel Prize-winning research and enables the purification and recycling of water across various sectors, including industrial, residential, and even space applications with NASA.

Aquaporin's commitment to addressing global water challenges is evident in its operational reach, with presence across Denmark, Singapore, Turkey, the United States, and China. By integrating biology, chemistry, and physics, the company endeavors to enhance the quality and accessibility of drinking water while promoting sustainable practices in water treatment and reuse.

Moving Forward

As the company moves forward with its strategic review, it remains cautious yet optimistic about securing the necessary financial backing to support its growth. Insights gleaned during the review process will likely play a crucial role in shaping Aquaporin’s future direction and could lead to innovative partnerships or transactions that align with its mission to revolutionize water filtration technology.

In conclusion, Aquaporin A/S stands at a critical juncture where strategic planning and financial fortitude intersect with the ambition of becoming a leading player in the water technology sphere. Stakeholders and potential investors alike are encouraged to stay informed as the company navigates these transformative pathways toward financial resilience and sustainable growth.